Litcius/Paper detail

Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021

Richard A. Teran, Kelly Walblay, Elizabeth L. Shane, Shannon Xydis, Stephanie Gretsch, Alexandra Gagner, Usha Samala, Hyeree Choi, Christy Zelinski, Stéphanie Black

2021MMWR Morbidity and Mortality Weekly Report110 citationsDOIOpen Access PDF

Abstract

In February 2021, through routine screening, the Chicago Department of Public Health (CDPH) identified a SARS-CoV-2 infection in a SNF resident >14 days after receipt of the second dose of a two-dose COVID-19 vaccination series. SARS-CoV-2 cases, vaccination status, and possible vaccine breakthrough infections were identified by matching facility reports with state case and vaccination registries. Among 627 persons with SARS-CoV-2 infection across 75 SNFs since vaccination clinics began, 22 SARS-CoV-2 infections were identified among 12 residents and 10 staff members across 15 facilities ≥14 days after receiving their second vaccine dose (i.e., breakthrough infections in fully vaccinated persons). Nearly two thirds (14 of 22; 64%) of persons with breakthrough infections were asymptomatic; two residents were hospitalized because of COVID-19, and one died. No facility-associated secondary transmission occurred. Although few SARS-CoV-2 infections in fully vaccinated persons were observed, these cases demonstrate the need for SNFs to follow recommended routine infection prevention and control practices and promote high vaccination coverage among SNF residents and staff members.

Topics & Concepts

MedicineAsymptomaticCoronavirus disease 2019 (COVID-19)Skilled Nursing FacilitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakTransmission (telecommunications)Emergency medicineGerontologyFamily medicineVirologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)EngineeringElectrical engineeringSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy